Success Metrics

Clinical Success Rate

83.3%

Based on 5 completed trials

Completion Rate

83%(5/6)

Active Trials

0(0%)

Results Posted

60%(3 trials)

Terminated

1(17%)

Phase Distribution

Ph not_applicable

100%

Phase Distribution

Early Stage

Mid Stage

Late Stage

Phase Distribution6 total trials

N/ANon-phased studies

6(100.0%)

Highest Phase Reached

Unknown

Trial Status & Enrollment

Completion Rate

83.3%

5 of 6 finished

Non-Completion Rate

16.7%

1 ended early

Currently Active

trials recruiting

Total Trials

all time

Status Distribution

Completed(5)

Terminated(1)

Detailed Status

Completed5

Terminated1

Development Timeline

Analytics

Development Status

Total Trials

Active

Success Rate

83.3%

Most Advanced

N/A

Trials by Phase

N/A6 (100.0%)

Trials by Status

terminated117%

completed583%

Recent Activity

0 active trials

Showing 5 of 6

terminatednot_applicable

Comparison of Nicotine Plasma Concentrations and Subjective Effects for Three Electronic Cigarettes vs Combustible Cigarettes and Nicotine Gum

NCT02269514

completednot_applicable

CogEcig: Cognitive Functioning and Electronic Cigarette

NCT01735487

View all 6 trials

Clinical Trials (6)

Showing 6 of 6 trials

NCT03974152Not Applicable

Effects of Nicotine Salt Aerosol on Cigarette Smokers

Terminated

NCT03861078Not Applicable

The Effect of Electronic Cigarette Liquid Characteristics in Smokers.

Completed

NCT03435562Not Applicable

Assessment of Two New Electronic Cigarettes in Cigarette Smokers

Completed

NCT02269514Not Applicable

Comparison of Nicotine Plasma Concentrations and Subjective Effects for Three Electronic Cigarettes vs Combustible Cigarettes and Nicotine Gum

Completed

NCT01735487Not Applicable

CogEcig: Cognitive Functioning and Electronic Cigarette

Completed

NCT01665066Not Applicable

Pharmacokinetic Profile of Toxic Substances and Nicotine in Electronic Cigarettes

Completed

All 6 trials loaded

Drug Details

Intervention Type: OTHER
Total Trials: 6